Transaction · 0001193125-26-355560

Robb Gary Charles

Robb Gary Charles, CBO, reported an open-market or private sale at CORCEPT THERAPEUTICS INC involving 10000.000000 shares for an estimated $1162572.00. Reported holdings after the transaction were 39716.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SCBO
CORTCORCEPT THERAPEUTICS INC
Estimated value-$1.16MShares × reported price
Shares traded10.0k$116.26 per share
Holdings after39.7kIndirect · Gary Charles Robb TTE Robb Revocable Trust
% of reported position traded20.11%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 49,716 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

CORT price since this filing

Daily closing prices, with the filing date and available return windows
CORT · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -23.4%1w ago -3.3%1d ago -3.1%
Returns since7d +3.9%30d -2.7%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001193125-26-355560
Common Stock
Transaction date
Aug 17, 2026
Filed Aug 18, 2026, 08:30 PM · 1d delay
Shares
10,000 sh
$116.26 per share
Estimated value
-$1.16M
Computed from shares × price
Holdings after
39,716 sh
Indirect · Gary Charles Robb TTE Robb Revocable Trust

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Large Holdings Reduction Large Sale
Filing-only score

+4 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Business Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Includes 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to th…

  2. F2

    Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.00 to $116.54 per share. Information on the exact number of shares sold at each…

  3. F3

    These shares are held by Gary Charles Robb TTE Robb Revocable Trust of which the Reporting Person is trustee.

  4. F4F5(2 footnotes)

    These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.

Original filing · 0001193125-26-355560
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

CORT